Ichthyosis, Lamellar clinical trials
The registry lists 7 studies for Ichthyosis, Lamellar across more than 10 countries. 1 are recruiting or about to start. 5 of them are mainly about Ichthyosis, Lamellar (how this is decided). Per ClinicalTrials.gov, last updated 2026-06-17.
Get an email when these change. Save the Ichthyosis, Lamellar studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Who runs them
National Cancer Institute (NCI) (1) · Northwestern University (1) · Centre Hospitalier Universitaire de Nice (1) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1) · Mayne Pharma International Pty Ltd (1) · Stiefel, a GSK Company (1) · Assistance Publique - Hôpitaux de Paris (1)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Oct 2027Lymphocyte Phenotype of Autosomal Recessive Congenital Ichthyoses Mutated NIPAL4 (Nipal4-nEDD) · Assistance Publique - Hôpitaux de Paris
Who these studies take
No Ichthyosis, Lamellar study is recruiting now.
Across all 7 studies, recruiting or not: 0% stop at 75 or younger and 0% at 65; 71% take children; 0% are for women only and 0% for men only; 14% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 7 of 7. search them.
- Lymphocyte Phenotype of Autosomal Recessive Congenital Ichthyoses Mutated NIPAL4 (Nipal4-nEDD)Not yet recruitingNCT07477769
- Treatment of the Recessive Nonbullous Congenital Ichthyosis by the Epigallocatechine CutaneousCompletedNCT01222000Phase 31 country
- A Safety, Efficacy and Systemic Exposure Study of CD5789 Cream in Adults and Adolescents With Lamellar IchthyosisTerminatedNCT03738800Phase 29 countries
- National Registry for Ichthyosis and Related DisordersCompletedNCT000746851 country
- The Efficacy and Safety of Secukinumab in Patients With IchthyosesCompletedNCT03041038Phase 21 country
- Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar IchthyosisCompletedNCT00282724Phase 2/39 countries
- Study of Scaling Disorders and Other Inherited Skin DiseasesCompletedNCT000012921 country